According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$43.49 Million, an increase over its 2024 earnings that were of -C$66.34 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.